Clinical Trial Update: Polyglutamate Paclitaxel Plus Carboplatin Compared With Paclitaxel Plus Carboplatin in Treating Patients With Advanced or Recurrent Non-Small Cell Lung Cancer [Phase 3]

View source ↗

Summary

Phase 3 trial comparing polyglutamate paclitaxel plus carboplatin versus paclitaxel plus carboplatin in advanced or recurrent non-small cell lung cancer; study …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• CARBOPLATIN (Carboplatin)
• PACLITAXEL (PACLITAXEL)
• polyglutamate paclitaxel (not specified)

Snippet

Sponsor: CTI BioPharma | Conditions: Lung Cancer | Phase 3 | Status: TERMINATED